Fig. 3From: Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosisBar charts for PET and MRI findings by patient group. CMV (A), focal FDG uptake (B), LGE presence (C) and co-localized FDG uptake and LGE presence (D)Back to article page